Federal Supply Schedule V797P5793X

Ionis Pharmaceuticals, Inc., headquartered in Carlsbad, California, was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) program by the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. The contract, effective August 15, 2025, through August 14, 2030, carries a ceiling value of $225,000.00 and operates without set-aside restrictions. This Federal Supply Schedule award represents a...

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network (VISN) 6 on December 1, 2025, valued at $1.69 million with an ultimate completion date of November 30, 2030. The contract procures standard radiopharmaceuticals for the Durham VA Medical Center, with a performance location in Dublin, Ohio. No set-aside designation was applied to this procurement, which falls under NAICS code 325412...

Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) was awarded a $216 million multiple-award Federal Supply Schedule contract by the Department of Veterans Affairs, Veterans Integrated Service Network 12, effective August 15, 2021, with an ultimate completion date of August 14, 2026. The contract operates under the Pharmaceuticals and Drugs (FSS-61-IB) schedule without small business set-aside designation and covers a broad portfolio of pharmaceutical and hematology-related...

This Federal Supply Schedule contract, awarded on March 15, 2025, represents a multiple-award indefinite delivery vehicle established between Veterans Integrated Service Network 12 and Cyclomedica USA, LLC for the procurement of drugs, pharmaceuticals, and hematology-related products under General Services Administration master schedule FSS-61-IB (Pharmaceuticals and Drugs). The contract carries a ceiling value of $225,000 with an ultimate completion date of March 14, 2030, providing a five-year...

The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned subsidiary of Cardinal Health, Inc., was awarded a multiple-award Federal Supply Schedule contract (GSA Master Schedule 61-IB) on June 1, 2025, for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract carries a ceiling value of $420.1 million and extends through May 31, 2030, with funding provided by the Department of Veterans Affairs through Veterans Integrated Service Network 12. No small...

Greer Laboratories, Inc., doing business as Stallergenes Greer, was awarded a Federal Supply Schedule Multiple Award Indefinite Delivery Vehicle under the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration Schedule. The contract, valued at $336,420.00, was awarded on May 15, 2016, with an ultimate completion date of May 31, 2026, and was funded by Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract involves no...

Merck Sharp & Dohme LLC has been awarded a $5.84 billion Federal Supply Schedule contract (FSS-61-IB) by the Department of Veterans Affairs for Pharmaceuticals and Drugs, effective June 1, 2025, through May 31, 2030. This multiple-award, non-set-aside contract serves as a master indefinite delivery vehicle enabling the Veterans Health Administration to procure a comprehensive portfolio of pharmaceutical products and related items through delivery orders issued across multiple Veterans...

The Department of Veterans Affairs, Veterans Integrated Service Network 21 awarded a single-award Indefinite Delivery Contract valued at $4.0 million to Optum Pharmacy 801, Inc. (a subsidiary of UnitedHealth Group Incorporated) on May 1, 2024, for contingency hazardous pharmaceutical compounding services supporting the VA Sierra Nevada Health Care System in Reno, Nevada. The contract period extends through September 30, 2028, comprising a base period and four optional one-year renewal periods....

Abbvie US LLC received a single-award Blanket Purchase Agreement from the Department of Veterans Affairs National Acquisition Center with a $15 million ceiling value, effective from August 1, 2025, through July 31, 2026. This BPA specifically covers the procurement of DUOPA (levodopa-carbidopa enteral suspension) and VYALEV (levodopa-carbidopa suspension), specialized pharmaceutical products used in the treatment of Parkinson's disease. The contract incorporates 2026 Public Law pricing updates...

Marlex Pharmaceuticals Inc., a Delaware-based minority-owned small disadvantaged business, was awarded a Federal Supply Schedule contract on February 1, 2025, under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB) to supply a broad portfolio of generic pharmaceutical products to Veterans Integrated Service Network 12. The contract establishes a five-year indefinite delivery vehicle with an $88 million ceiling value and multiple award status, extending...